disulfiram has been researched along with Pre-Eclampsia in 1 studies
Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disulfiram is a dehydrogenase inhibitor used to treat alcoholism and has been suggested as a proteasome inhibitor." | 1.48 | Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome. ( Brownfoot, FC; Cannon, P; Hannan, NJ; Hastie, R; Kaitu'u-Lino, TJ; Nguyen, V; Tong, S; Ye, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hastie, R | 1 |
| Ye, L | 1 |
| Hannan, NJ | 1 |
| Brownfoot, FC | 1 |
| Cannon, P | 1 |
| Nguyen, V | 1 |
| Tong, S | 1 |
| Kaitu'u-Lino, TJ | 1 |
1 other study available for disulfiram and Pre-Eclampsia
| Article | Year |
|---|---|
Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Disulfiram; Endoglin; Enzyme-Linked Immunosorbent Assay; Fema | 2018 |